Author:
Gao Hua,Zhang Jing-Yi,Zhao Li-Jie,Guo Yuan-Yuan
Subject
Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry
Reference109 articles.
1. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors;N.Z. Lu, S.E. Wardell, K.L. Burnstein, D. Defranco, P.J. Fuller, V. Giguere, R.B. Hochberg, L. McKay, J.M. Renoir, N.L. Weigel, E.M. Wilson, D.P. McDonnell, J.A. Cidlowski, International union of pharmacology. LXV;Pharmacol. Rev.,2006
2. Regulation of androgen action;Roy;Vitam. Horm.,1999
3. Current status and future perspectives of androgen receptor inhibition therapy for prostate cancer: a comprehensive review;Kim;Biomolecules,2021
4. Targeting androgen receptor degradation with PROTACs from bench to bedside;Jia;Biomed. Pharmacother.,2023
5. An overview of next-generation androgen receptor-targeted therapeutics in development for the treatment of prostate cancer;Mohler;Int. J. Mol. Sci.,2021